DLG4 and Alzheimer disease: When complement activity was blocked by crossing either the PS2APP or the Tau P301S AD mouse model with the constitutive C3 knock out (KO) mouse model, reduced loss of PSD-95 staining near plaques in the PS2APP mice and limited neurodegeneration in the Tau P301S mouse model was observed.